• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Low-lead exposure in childhood associated with worse cognitive performance [Pediatrics Classics Series]

byLeah Carr, MDandLewis First, MD
October 18, 2014
in Pediatrics, Pediatrics Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Among children exposed to lead early in life, serum lead levels at 24 months of age were significantly associated with decreased cognitive performance on measures of intelligence and educational achievement at 10 years old.

2. Each 0.48 μmol/L (10 μg/dL) increase in serum lead at 24 months of age was associated with a 5.8 point decline in a measure of intelligence quotient and an 8.9 point decline in educational achievement score during cognitive testing at 10 years of age.

Original Date of Publication: December 1992

Study Rundown: At the time of this publication, prior studies investigating early, low-level lead exposure and cognition later in life had mixed findings. Previous reports assessed the potential connection between lead levels and cognitive performance into preschool years. This was the first study to investigate the effects of early low-level lead exposure on cognitive performance into school age. One hundred forty-eight children were assessed from birth to 10 years of age for serum lead levels and cognitive development through intelligence quotient (IQ) testing via the Wechsler Intelligence Scale for Children-Revised (WISC-R) and the Kaufman Test of Educational Achievement Brief Form (K-TEA). Findings indicated that serum lead levels at 24 months of age were significantly associated with IQ and neuropsychiatric performance at 10 years old, a finding which was upheld after controlling for covariates. There is no known reason as to why children are most vulnerable to lead toxicity in this specific time frame. This study was limited by the potential role of bias towards children available for follow-up as multiple participants were lost from 5 years of age to 10 years old. In addition, this cohort was of higher socioeconomic status (SES) and intelligence than the average citizen, which may have allowed for an enhanced view of the cognitive effects of lead, but makes the findings less generalizable compared to previous study cohorts of lower SES who were more likely to be exposed to environmental lead. This study indicated that even at low levels, early lead exposure is linked to poor cognitive development through school age. Combined with previous work, these findings encouraged the Centers for Disease Control to lower the benchmark for toxic lead levels to the current 0.24 μmol/L or 5 μg/dL.

Click to read the study in Pediatrics

RELATED REPORTS

Coffee consumption associated with better cognitive performance in patients with atrial fibrillation

Asthma may be associated with impaired memory function in children

Double dose extracorporeal shockwave may be more effective for plantar flexor spasticity of ankle in stroke patients

In-Depth [prospective cohort study]: Two hundred forty-nine infants born between August 1979 and August 1981 were recruited from Brigham and Women’s Hospital in Boston, Massachusetts with umbilical blood lead levels in the ranges required for eligibility. Infants were considered for study inclusion if their umbilical cord blood lead levels were below the 10th percentile at the time of the study (< 0.15 μmol/L or 3 μg/dL), around the 50­th percentile (0.31 μmol/L or 6.5 μg/dL), or above the 90th percentile (> 0.48 μmol/L or 10 μg/dL) indicating, respectively, “low,” “medium,” or “high” prenatal lead exposure. Infants’ lead levels and development were evaluated at 6, 12, 18, 24, and 57 months of age and then again at 10 years old. Primary cognitive outcomes were assessed through the use of the WISC-R and K-TEA.

Of the initial cohort, 148 children were included in the final analysis as they completed the entire study course. Of those, 116 had serum lead measurements at all 7 time points, including birth (mean 0.14 μmol/L or 2.9 μg/dL). Multiple regression analysis was completed with appropriate adjustment for confounders. Overall, participants had cognitive scores about 1 SD above the national average. After controlling for covariates, only the lead levels of children at 24 months of age (mean lead level < 0.34 μmol/L or < 7 μg/dL) were significantly associated with cognitive performance including the full-scale WISC-R IQ and K-TEA battery composite. Each 0.48 μmol/L (10 μg/dL) increase in serum lead was associated with a 5.8 point decline in the IQ measure and 8.9 point decline in the K-TEA composite (p < 0.01, p < 0.001, respectively). No significant association between lead levels and cognitive scores was seen at any other age.

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: blood lead levelcognitioncognitive developmentleadlead levellead poisoning
Previous Post

PROS network study examines pubertal onset by race/ethnic groups [Pediatrics Classics Series]

Next Post

Partial meniscectomy not superior to sham surgery for meniscal tear

RelatedReports

European data showed coffee consumption associated with lower mortality
Cardiology

Coffee consumption associated with better cognitive performance in patients with atrial fibrillation

May 19, 2025
Chronic Disease

Asthma may be associated with impaired memory function in children

November 21, 2024
Chronic Disease

Double dose extracorporeal shockwave may be more effective for plantar flexor spasticity of ankle in stroke patients

October 8, 2024
Quick Take: Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents A Voxelwise and Genome-Wide Association Study
Chronic Disease

Predicting adherence to gamified cognitive training using early phase game performance data

October 7, 2024
Next Post
Physical therapy equal to surgery for symptomatic meniscal tears

Partial meniscectomy not superior to sham surgery for meniscal tear

Erlotinib does not demonstrate increased survival in ovarian epithelial carcinomas

Erlotinib does not demonstrate increased survival in ovarian epithelial carcinomas

Soaring rates of peripheral artery disease, now over 200 million cases worldwide

Elderly anemic patients at higher risk of postoperative mortality after vascular procedures

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer
  • Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients
  • Rectoscopy alone may be sufficient to evaluate for remission of ulcerative colitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.